Working… Menu
Trial record 2 of 3 for:    MGTA-456

A Follow-up Study in Patients With Inherited Metabolic Disorders (IMD) Who Underwent Hematopoietic Stem Cell Transplantation (HSCT) With MGTA-456 (IMD-002)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04008849
Recruitment Status : Enrolling by invitation
First Posted : July 4, 2019
Last Update Posted : July 10, 2019
Information provided by (Responsible Party):
Magenta Therapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : December 2024
Estimated Study Completion Date : May 2025